Abstract

Alzheimer’s disease (AD), a neurodegenerative disorder marked by accumulation of extracellular amyloid-β (Aβ) plaques leads to progressive loss of memory and cognitive function. Resting-state fMRI (RS-fMRI) studies have provided links between these two observations in terms of disruption of default mode and task-positive resting-state networks (RSNs). Important insights underlying these disruptions were recently obtained by investigating dynamic fluctuations in RS-fMRI signals in old TG2576 mice (a mouse model of amyloidosis) using a set of quasi-periodic patterns (QPP). QPPs represent repeating spatiotemporal patterns of neural activity of predefined temporal length. In this article, we used an alternative methodology of co-activation patterns (CAPs) that represent instantaneous and transient brain configurations that are likely contributors to the emergence of commonly observed RSNs and QPPs. We followed a recently published approach for obtaining CAPs that divided all time frames, instead of those corresponding to supra-threshold activations of a seed region as done traditionally, to extract CAPs from RS-fMRI recordings in 10 TG2576 female mice and eight wild type littermates at 18 months of age. Subsequently, we matched the CAPs from the two groups using the Hungarian method and compared the temporal (duration, occurrence rate) and the spatial (lateralization of significantly co-activated and co-deactivated voxels) properties of matched CAPs. We found robust differences in the spatial components of matched CAPs. Finally, we used supervised learning to train a classifier using either the temporal or the spatial component of CAPs to distinguish the transgenic mice from the WT. We found that while duration and occurrence rates of all CAPs performed the classification with significantly higher accuracy than the chance-level, blood oxygen level-dependent (BOLD) signals of significantly activated voxels from individual CAPs turned out to be a significantly better predictive feature demonstrating a near-perfect classification accuracy. Our results demonstrate resting-state co-activation patterns are a promising candidate in the development of a diagnostic, and potentially, prognostic RS-fMRI biomarker of AD.

Highlights

  • Alzheimer’s disease (AD) is a neurodegenerative disorder that causes progressive loss of learning abilities, memory, and overall cognitive function

  • Test-statistics are calculated using this functional connectivity (FC) time series and compared against the null hypothesis of stationarity (Hindriks et al, 2016). Another approach consists of a point-process analysis (Liu and Duyn, 2013; Liu et al, 2018) in which fMRI time frames where the signal of a given region of interest crosses a specific percentile threshold, are clustered to identify different co-activation patterns (CAPs)

  • We investigated the spatial and temporal properties of resting-state co-activation patterns extracted in a mouse model of Alzheimer’s disease at a very old age

Read more

Summary

INTRODUCTION

Alzheimer’s disease (AD) is a neurodegenerative disorder that causes progressive loss of learning abilities, memory, and overall cognitive function. Test-statistics are calculated using this FC time series and compared against the null hypothesis of stationarity (Hindriks et al, 2016) Another approach consists of a point-process analysis (Liu and Duyn, 2013; Liu et al, 2018) in which fMRI time frames where the signal of a given region of interest (i.e., seed) crosses a specific percentile threshold, are clustered to identify different co-activation patterns (CAPs). We used the methodology of GutierrezBarragan et al, to identify CAPs in a cohort of old (18months) TG2576 (mouse-model of amyloidosis) mice and their age-matched control In this cohort, Belloy et al (2018) identified changes in a set of recurring Spatio-temporal patterns of neural activity of predefined temporal length called the quasiperiodic patterns (QPPs). We hypothesized that the CAP properties will accurately distinguish the transgenic animals from healthy controls and argue that it could be effective in the development of a biomarker for Alzheimer’s disease

MATERIALS AND METHODS
Ethical Statement
RESULTS
DISCUSSION
ETHICS STATEMENT
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call